Fundraising Fox
Find your path to Hong
42 people in our graph can introduce you to Hong.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Mike Carusi to introduce you to Hong
You →Mike · together at Lightstone Ventures →Hong
Ask Jamie Chen to introduce you to Hong
You →Jamie · 11 people · together at Lightstone Ventures →Hong
Sign up to find every way you can get introduced to Hong
- Your email: the people you already email who know Hong
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Hong
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Advisor to Lightstone Ventures and President, CEO and co-founder of Tallac Therapeutics. Hong previously served as Chief Scientific Officer at ALX Oncology leading clinical advancement and held leadership positions at Pfizer and Wyeth Research across therapeutic areas.
Colleagues at Lightstone Ventures
Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Doug Treco
Advisor at Lightstone Ventures
Doug Treco, Ph.D.
Advisor at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures
H. Martin Seidel
Advisor at Lightstone Ventures
H. Martin Seidel, Ph.D.
Advisor at Lightstone Ventures
Frequently asked questions
- Who is Hong I. Wan, Ph.D.?
- Advisor to Lightstone Ventures and President, CEO and co-founder of Tallac Therapeutics. Hong previously served as Chief Scientific Officer at ALX Oncology leading clinical advancement and held leadership positions at Pfizer and Wyeth Research across therapeutic areas.
- Where does Hong I. Wan, Ph.D. work?
- Hong I. Wan, Ph.D. is Advisor at Lightstone Ventures.